Page last updated: 2024-10-25

ciprofloxacin and Lung Injury, Acute

ciprofloxacin has been researched along with Lung Injury, Acute in 2 studies

Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.

Research Excerpts

ExcerptRelevanceReference
"aeruginosa-induced NET formation and lung inflammation."1.72CLEC5A is critical in Pseudomonas aeruginosa-induced NET formation and acute lung injury. ( Chiu, CH; Hsieh, SL; Peng, YC; Sung, PS; Yang, SP, 2022)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Sung, PS1
Peng, YC1
Yang, SP1
Chiu, CH1
Hsieh, SL1
Wilson, CN1
Vance, CO1
Doyle, TM1
Brink, DS1
Matuschak, GM1
Lechner, AJ1

Other Studies

2 other studies available for ciprofloxacin and Lung Injury, Acute

ArticleYear
CLEC5A is critical in Pseudomonas aeruginosa-induced NET formation and acute lung injury.
    JCI insight, 2022, 09-01, Volume: 7, Issue:18

    Topics: Acute Lung Injury; Animals; Caspases; Ciprofloxacin; Cytokines; Lectins, C-Type; Lipopolysaccharides

2022
A novel post-exposure medical countermeasure L-97-1 improves survival and acute lung injury following intratracheal infection with Yersinia pestis.
    Innate immunity, 2012, Volume: 18, Issue:3

    Topics: Acute Lung Injury; Animals; Ciprofloxacin; Disease Models, Animal; Drug Therapy, Combination; Humans

2012